Submission Details

Submitter:

Classification:
Definitive
GENCC:100001
Gene:
Disease:
epidermolysis bullosa, junctional 7, with interstitial lung disease and nephrotic syndrome
Mode Of Inheritance:
Autosomal recessive
Evaluated Date:
05/09/2022
Evidence/Notes:

The ITGA3 gene is located on chromosome 17 at q21.33 and encodes the protein integrin alpha 3 which dimerizes with integrin beta 1 to form the α3β1 integrin duplex that functions as an adhesion molecule between the podocyte and glomerular basement membrane.

ITGA3 was first reported in relation to autosomal recessive 'interstitial lung disease, nephrotic syndrome, and epidermolysis bullosa, congenital' in 2012 (Has et al., PMID: 22512483, OMIM:614748). The mechanism of pathogenicity is known to be loss of function. Interstitial lung disease, nephrotic syndrome, and epidermolysis bullosa, congenital is characterized by significant protein loss in the urine, severe lung disease and/or blistering skin disease within the first months of life causing generalized edema, respiratory failure and/or skin/nail abnormalities.

At least 10 variants (frameshift, splice, missense) have been reported in 10 probands in 9 publications (PMIDs: 22512483, 23114595, 25810266, 26854491, 32198874, 34023363, 34751145, 33768705 included in this curation). More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached, considering case-level data.

This gene-disease relationship is also supported by animal models, expression studies, in vitro functional assays, and rescue assays (PMIDs: 9211352, 30466509, 9151677, 8951069, 17015618, 19118220). In particular, ITGA3 knockout mice caused congenital epidermolysis bullosa-phenotype (PMID 9211352), abnormal nephrogenesis and abnormal lung morphogenesis (PMID 30466509). Transgenic mice with ITGA3 knockout isolated to the podocyte (2.5P-Cre; ITGA3fl /fl) developed nephrotic syndrome with severe proteinuria, focal segmental glomerulosclerosis and podocyte effacement (PMID 17015618). Transgenic mice with ITGA3 knockout isolated to the skin (K14-Cre; ITGA3fl /fl) developed severe skin defects recapitulating the epidermolysis bullosa-phenotype (PMID 19118220). In-vitro functional assays demonstrated increased fibronectin expression in skin, kidney and lung cells of a patient with ITGA3 mutation and interstitial lung disease, nephrotic syndrome, and epidermolysis bullosa, congenital (PMID 30466509). This was associated with an increased keratinocyte migratory phenotype (also seen in the K14-Cre; ITGA3fl /fl mouse), which could be rescued using by retroviral re-expression of ITGA3 (PMID 30466509). A total of 5.5/6 pts. for experimental evidence was reached.

In summary, there is definitive evidence supporting the relationship between ITGA3 and autosomal recessive interstitial lung disease, nephrotic syndrome, and epidermolysis bullosa, congenital. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time.

PubMed IDs:
8951069 9151677 9211352 17015618 19118220 22512483 23114595 25810266 26854491 30466509 33768705 34023363
Public Report:
Assertion Criteria:
Submitter Submitted Date:
12/05/2025

The GenCC data are available free of restriction under a CC0 1.0 Universal (CC0 1.0) Public Domain Dedication. The GenCC requests that you give attribution to GenCC and the contributing sources whenever possible and appropriate. The accepted Flagship manuscript is now available from Genetics in Medicine (https://www.gimjournal.org/article/S1098-3600(22)00746-8/fulltext).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. The GenCC does not independently verify the submitted information. Though the information is obtained from sources believed to be reliable, no warranty, expressed or implied, is made regarding accuracy, adequacy, completeness, reliability or usefulness of any information. This disclaimer applies to both isolated and aggregate uses of the information. The information is provided on an "as is" basis, collected through periodic submission and therefore may not represent the most up-to-date information from the submitters. If you have questions about the medical relevance of information contained on this website, please see a healthcare professional; if you have questions about specific gene-disease claims, please contact the relevant sources; and if you have questions about the representation of the data on this website, please contact gencc@thegencc.org.